Etizolam



Indications and Reactions:

Role Indications Reactions
Secondary
Depression 17.2%
Insomnia 12.4%
Suicide Attempt 8.3%
Product Used For Unknown Indication 8.0%
Maternal Exposure During Pregnancy 7.2%
Drug Use For Unknown Indication 6.8%
Hiv Infection 5.5%
Overdose 5.0%
Schizophrenia 4.6%
Depressed Mood 3.7%
Fatigue 3.7%
Anxiety 2.6%
Intentional Overdose 2.5%
Constipation 2.4%
Hypertension 2.4%
Infection 1.8%
Pyrexia 1.8%
Atypical Mycobacterial Infection 1.7%
Glioblastoma 1.4%
Panic Disorder 1.1%
Drug Rash With Eosinophilia And Systemic Symptoms 12.9%
Suicide Attempt 10.6%
Rhabdomyolysis 7.1%
Serotonin Syndrome 7.1%
Blepharospasm 5.9%
Drug Withdrawal Syndrome Neonatal 4.7%
Eosinophilia 4.7%
Interstitial Lung Disease 4.7%
Motor Developmental Delay 4.7%
Overdose 4.7%
Pneumonia Aspiration 4.7%
Delirium 3.5%
Dyspnoea 3.5%
Sepsis 3.5%
Supraventricular Tachycardia 3.5%
Ventricular Arrhythmia 3.5%
Withdrawal Syndrome 3.5%
Gastric Ulcer Haemorrhage 2.4%
Inappropriate Antidiuretic Hormone Secretion 2.4%
Myocardial Ischaemia 2.4%
Concomitant
Product Used For Unknown Indication 16.8%
Rheumatoid Arthritis 14.3%
Drug Use For Unknown Indication 10.3%
Prophylaxis 10.0%
Insomnia 9.4%
Depression 6.6%
Multiple Myeloma 5.3%
Hypertension 4.9%
Constipation 3.4%
Schizophrenia 2.4%
Crohn's Disease 2.0%
Diabetes Mellitus 1.9%
Pain 1.8%
Postoperative Care 1.8%
Gastric Ulcer 1.5%
Hepatitis C 1.5%
Hyperlipidaemia 1.5%
Premedication 1.5%
Adverse Event 1.5%
Breast Cancer 1.4%
Pneumonia 9.0%
Liver Disorder 8.2%
Pyrexia 8.2%
White Blood Cell Count Decreased 8.2%
Gastric Cancer 5.9%
Rhabdomyolysis 5.9%
Malaise 5.1%
Anaemia 4.7%
Somnolence 4.7%
Completed Suicide 3.9%
Interstitial Lung Disease 3.9%
Renal Impairment 3.9%
Rheumatoid Arthritis 3.9%
Thrombocytopenia 3.9%
Neuroleptic Malignant Syndrome 3.5%
Platelet Count Decreased 3.5%
Sepsis 3.5%
Tremor 3.5%
Vomiting 3.5%
Cerebral Haemorrhage 3.1%
Interacting
Insomnia 50.0%
Hypertension 25.0%
Sciatica 25.0%
Faeces Discoloured 100.0%